505 related articles for article (PubMed ID: 28900507)
1. Targeting MicroRNAs in Prostate Cancer Radiotherapy.
Ni J; Bucci J; Chang L; Malouf D; Graham P; Li Y
Theranostics; 2017; 7(13):3243-3259. PubMed ID: 28900507
[TBL] [Abstract][Full Text] [Related]
2. microRNA-16-5p enhances radiosensitivity through modulating Cyclin D1/E1-pRb-E2F1 pathway in prostate cancer cells.
Wang F; Mao A; Tang J; Zhang Q; Yan J; Wang Y; Di C; Gan L; Sun C; Zhang H
J Cell Physiol; 2019 Aug; 234(8):13182-13190. PubMed ID: 30536619
[TBL] [Abstract][Full Text] [Related]
3. Autophagy-regulating microRNAs: potential targets for improving radiotherapy.
Li H; Jin X; Chen B; Li P; Li Q
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1623-1634. PubMed ID: 29971533
[TBL] [Abstract][Full Text] [Related]
4. Role of MicroRNAs in Treatment Response in Prostate Cancer.
Razdan A; de Souza P; Roberts TL
Curr Cancer Drug Targets; 2018; 18(10):929-944. PubMed ID: 29644941
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Non-coding RNAs in Chemo- and Radioresistance of Colorectal Cancer.
Fanale D; Castiglia M; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():207-28. PubMed ID: 27573902
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
Gong P; Zhang T; He D; Hsieh JT
Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
[TBL] [Abstract][Full Text] [Related]
7. microRNAs identified in prostate cancer: Correlative studies on response to ionizing radiation.
Labbé M; Hoey C; Ray J; Potiron V; Supiot S; Liu SK; Fradin D
Mol Cancer; 2020 Mar; 19(1):63. PubMed ID: 32293453
[TBL] [Abstract][Full Text] [Related]
8. Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach.
Chang L; Ni J; Beretov J; Wasinger VC; Hao J; Bucci J; Malouf D; Gillatt D; Graham PH; Li Y
Sci Rep; 2017 Feb; 7():41834. PubMed ID: 28225015
[TBL] [Abstract][Full Text] [Related]
9. Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.
Chang L; Graham PH; Hao J; Bucci J; Cozzi PJ; Kearsley JH; Li Y
Cancer Metastasis Rev; 2014 Sep; 33(2-3):469-96. PubMed ID: 24445654
[TBL] [Abstract][Full Text] [Related]
10. Network-based analysis of prostate cancer cell lines reveals novel marker gene candidates associated with radioresistance and patient relapse.
Seifert M; Peitzsch C; Gorodetska I; Börner C; Klink B; Dubrovska A
PLoS Comput Biol; 2019 Nov; 15(11):e1007460. PubMed ID: 31682594
[TBL] [Abstract][Full Text] [Related]
11. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer.
Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J
Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472
[TBL] [Abstract][Full Text] [Related]
12. Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy.
Hao J; Graham P; Chang L; Ni J; Wasinger V; Beretov J; Deng J; Duan W; Bucci J; Malouf D; Gillatt D; Li Y
Oncotarget; 2016 Nov; 7(45):74269-74285. PubMed ID: 27708237
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-107 enhances radiosensitivity by suppressing granulin in PC-3 prostate cancer cells.
Lo HC; Hsu JH; Lai LC; Tsai MH; Chuang EY
Sci Rep; 2020 Sep; 10(1):14584. PubMed ID: 32883962
[TBL] [Abstract][Full Text] [Related]
14. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
[TBL] [Abstract][Full Text] [Related]
15. miRNAs and radiotherapy response in prostate cancer.
Konoshenko MY; Bryzgunova OE; Laktionov PP
Andrology; 2021 Mar; 9(2):529-545. PubMed ID: 33053272
[TBL] [Abstract][Full Text] [Related]
16. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs in Prostate Cancer Following Radiotherapy: Towards Predicting Response to Radiation Treatment.
Petrović N; Stanojković TP; Nikitović M
Curr Med Chem; 2022; 29(9):1543-1560. PubMed ID: 34348602
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs and Their Impact on Radiotherapy for Cancer.
Mueller AK; Lindner K; Hummel R; Haier J; Watson DI; Hussey DJ
Radiat Res; 2016 Jun; 185(6):668-77. PubMed ID: 27223830
[TBL] [Abstract][Full Text] [Related]
19. Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.
Chang L; Graham PH; Ni J; Hao J; Bucci J; Cozzi PJ; Li Y
Crit Rev Oncol Hematol; 2015 Dec; 96(3):507-17. PubMed ID: 26253360
[TBL] [Abstract][Full Text] [Related]
20. miR-668 enhances the radioresistance of human breast cancer cell by targeting IκBα.
Luo M; Ding L; Li Q; Yao H
Breast Cancer; 2017 Sep; 24(5):673-682. PubMed ID: 28138801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
